Cited by 648BRCA gene mutations in cancerDNA Repair MechanismsPARP inhibition in cancer therapy

The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

Welcsh, P. L.·2001·Human Molecular Genetics

Open this paper in CoChat — free account

Abstract

Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose individuals to breast and ovarian cancers. Progress in determining the function of BRCA1 and BRCA2 suggests that they are involved in two fundamental cellular processes: DNA damage repair and transcriptional regulation. We evaluate current knowledge of BRCA1 and BRCA2 functions to explain why mutations in BRCA1 and BRCA2 lead specifically to breast and ovarian cancer. The BRCA1 and BRCA2 genes contain unusually high densities of repetitive elements. These features of the BRCAs genomic regions contribute to chromosomal instability of these genes. We propose that somatic alterations of BRCA1 and BRCA2 are common and driven by rearrangements between repetitive elements. Inherited and somatic mutations occur in BRCA1 and BRCA2; virtually all somatic mutations are the result of large genomic rearrangements. What are the consequences of such large somatic mutations of BRCA1 and BRCA2 in women with or without inherited mutations? The breast and ovary are estrogen-responsive tissues. Beginning in puberty, the breast epithelium proliferates rapidly in response to fluctuating levels of estrogen. We present a genetic model outlining how BRCA-deficient cells may gain uncontrolled proliferation leading to tumor formation. Central to this model of BRCA-mediated tumorigenesis are estrogen-mediated proliferation of breast and ovarian epithelium and the distinctive genomic context of the BRCA genes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/hmg/10.7.705

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K. N., Seal, S., Tran, T. D., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,918
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Cancer risks in BRCA2 mutation carriers.
Olsson, H. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,404
BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L., Haugen-Strano, A., Swensen, J., & Miki, Y. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,378
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221

Flagged first, then by citations

Show all 93 references

1 of the 93 references couldn’t be matched to a known paper.

Sorted by citations

Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J.-O., Hochhauser, D., Arnold, D., Oh, D.-Y., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903387 · Cited by 2,302
Genetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Gelmon, K. A., Tischkowitz, M. D., MacKay, H. J., Swenerton, K. D., Robidoux, A., Tonkin, K. S., Hirte, H. W., Huntsman, D. D., Clemons, M. J., Gilks, C. B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,130
Molecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 977
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and BRCA2
King, M. (2001) · JAMA · doi:10.1001/jama.286.18.2251 · Cited by 776
Breast Cancer Epidemiology, Prevention, and Screening
Winters, S., Martin, C., Murphy, D. E., & Shokar, N. K. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.002 · Cited by 721
RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination
Metzger, M. B., Pruneda, J. N., Klevit, R. E., & Weissman, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.026 · Cited by 608
Comparative Genomics and Molecular Dynamics of DNA Repeats in Eukaryotes
Richard, G., Kerrest, A., & Dujon, B. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00011-08 · Cited by 590
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
Brzović, P. S., Rajagopal, P., Hoyt, D. W., King, M., & Klevit, R. E. (2001) · Nature Structural Biology · doi:10.1038/nsb1001-833 · Cited by 511
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
Clarke, R., Liu, M. C., Bouker, K., Gu, Z.-P., Lee, R., Zhu, Y., Skaar, T., Gomez, B. P., O'Brien, K. A., Wang, Y., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206937 · Cited by 514
CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair
Esashi, F., Christ, N., Gannon, J., Liu, Y., Hunt, T., Jasin, M., & West, S. C. (2005) · Nature · doi:10.1038/nature03404 · Cited by 473
The myc Oncogene: arvelouslomplex
Oster, S. K., Ho, C. S. W., Soucie, E. L., & Penn, L. Z. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 465
Targeted nanopore sequencing with Cas9-guided adapter ligation
Gilpatrick, T., Lee, I., Graham, J. E., Raimondeau, E., Bowen, R., Heron, A., Downs, B. M., Sukumar, S. V., Sedlazeck, F. J., & Timp, W. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0407-5 · Cited by 432
Recombinational DNA repair and human disease
Thompson, L. H., & Schild, D. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00224-5 · Cited by 417
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
Lipkowitz, S., & Weissman, A. M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3120 · Cited by 422
DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains
Yu, X., & Chen, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9478-9486.2004 · Cited by 410
Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
Proia, T. A., Keller, P. J., Gupta, P. B., Klebba, I., Jones, A. D., Sedic, M., Gilmore, H. L., Tung, N., Naber, S. P., Schnitt, S. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.007 · Cited by 393
Homologous repair of DNA damage and tumorigenesis:the BRCA connection
Jasin, M. (2002) · Oncogene · doi:10.1038/sj.onc.1206176 · Cited by 363
Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex
Brzovic, P. S., Keeffe, J. R., Nishikawa, H., Miyamoto, K., Fox, D., Fukuda, M., Ohta, T., & Klevit, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0836054100 · Cited by 346
Hereditary Breast Cancer: The Era of New Susceptibility Genes
Apostolou, P., & Fostira, F. (2013) · BioMed Research International · doi:10.1155/2013/747318 · Cited by 379
Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer
Bao, Y., Wang, L., Shi, L., Yun, F., Liu, X., Chen, Y., Chen, C., Ren, Y., & Jia, Y. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0162-0 · Cited by 355
Altered adenosine-to-inosine RNA editing in human cancerPreprint
Paz-Yaacov, N., Levanon, E. Y., Amariglio, N., Heimberger, A. B., Ram, Z., Constantini, S., Barbash, Z. S., Adamsky, K., Safran, M., Hirshberg, A., et al. (2007) · Genome Research · doi:10.1101/gr.6493107 · Cited by 347
Structure of an E3:E2∼Ub Complex Reveals an Allosteric Mechanism Shared among RING/U-box Ligases
Pruneda, J. N., Littlefield, P. J., Soss, S. E., Nordquist, K. A., Chazin, W. J., Brzovic, P. S., & Klevit, R. E. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.001 · Cited by 333
DNA double strand break repair and chromosomal translocation: Lessons from animal models
Ferguson, D. O., & Alt, F. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204767 · Cited by 333
The role of PARP in DNA repair and its therapeutic exploitation
Javle, M. M., & Curtin, N. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.382 · Cited by 339
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Rebbeck, T. R., Friebel, T. M., Friedman, E., Hamann, U., Huo, D., Kwong, A., Oláh, E., Olopade, O. I., Solano, A. R., Teo, S., et al. (2018) · Human Mutation · doi:10.1002/humu.23406 · Cited by 319
DNA Damage Response Genes and the Development of Cancer Metastasis
Broustas, C. G., & Lieberman, H. B. (2014) · Radiation Research · doi:10.1667/rr13515.1 · Cited by 284
KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
Cicenas, J., Kvederavičiūtė, K., Meskinyte, I., Meškinytė-Kaušilienė, E., Skeberdytė, A., & Cicenas, J. (2017) · Cancers · doi:10.3390/cancers9050042 · Cited by 273
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Gorodetska, I., Kozeretska, I. A., & Dubrovska, A. (2019) · Journal of Cancer · doi:10.7150/jca.30410 · Cited by 302
The Genetic Epidemiology of Breast Cancer Genes
Thompson, D. J., & Easton, D. F. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048770.90334.3b · Cited by 272
BRCA1 and BRCA2 mutations and treatment strategies for breast cancer
Godet, I., & Gilkes, D. M. (2017) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000228 · Cited by 282
Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function
Xi, T., Jones, I. M., & Mohrenweiser, H. W. (2004) · Genomics · doi:10.1016/j.ygeno.2003.12.016 · Cited by 245
Overall survival results from the POLO trial: A Phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer
Kindler, H. L., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J. O., Hochhauser, D., Arnold, D., Oh, D.-Y., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01604 · Cited by 244
Mass Spectrometric and Mutational Analyses Reveal Lys-6-linked Polyubiquitin Chains Catalyzed by BRCA1-BARD1 Ubiquitin Ligase
Nishikawa, H., Ooka, S., Sato, K., Arima, K., Okamoto, J., Klevit, R. E., Fukuda, M., & Ohta, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308540200 · Cited by 194
Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
Faraoni, I., & Graziani, G. (2018) · Cancers · doi:10.3390/cancers10120487 · Cited by 239
Risk of second cancer among women with breast cancer
Mellemkjær, L., Friis, S., Olsen, J. H., Scélo, G., Hemminki, K., Tracey, E. A., Andersen, A., Brewster, D., Pukkala, ., McBride, M. L., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21651 · Cited by 231
Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis
Yue, W., Yager, J. D., Wang, J.-P., Jupe, E. R., & Santen, R. J. (2012) · Steroids · doi:10.1016/j.steroids.2012.11.001 · Cited by 241
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Brasseur, K., Gévry, N. Y., & Asselin, É. (2016) · Oncotarget · doi:10.18632/oncotarget.14021 · Cited by 230
Challenges in biomarker discovery: combining expert insights with statistical analysis of complex omics data
McDermott, J., Wang, J., Mitchell, H. D., Webb‐Robertson, B., Hafen, R., Ramey, J., & Rodland, K. (2012) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2012.718329 · Cited by 232
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
Paul, A. (2014) · Frontiers in bioscience · doi:10.2741/4230 · Cited by 224
Linking the Cellular Functions ofBRCAGenes to Cancer Pathogenesis and Treatment
Venkitaraman, A. R. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151422 · Cited by 201
Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
Mengwasser, K. E., Adeyemi, R. O., Leng, Y., Choi, M. Y., Clairmont, C. S., D’Andrea, A. D., & Elledge, S. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.12.008 · Cited by 203
Expression and function of the insulin receptor substrate proteins in cancer
Mardilovich, K., Pankratz, S. L., & Shaw, L. M. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-14 · Cited by 192
Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase
Eakin, C. M., MacCoss, M. J., Finney, G. L., & Klevit, R. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610887104 · Cited by 195
The biology of breast carcinoma
Keen, J. C., & Davidson, N. E. (2003) · Cancer · doi:10.1002/cncr.11126 · Cited by 195
Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers
Wang, Z. C., Lin, M. G., Wei, L. J., Li, C., Miron, A., Lodeiro, G., Harris, L. N., Ramaswamy, S., Tanenbaum, D. M., Meyerson, M. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2570 · Cited by 190
Variation in BRCA1 cancer risks by mutation position.
Thompson, D. J., & Easton, D. F. (2002) · PubMed · Cited by 187
The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage
Bahassi, E. M., Ovesen, J. L., Riesenberg, A. L., Bernstein, W. Z., Hasty, P., & Stambrook, P. J. (2008) · Oncogene · doi:10.1038/onc.2008.17 · Cited by 180
Pathology of hereditary breast cancer
van der Groep, P., van der Wall, E., & van Diest, P. J. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0010-3 · Cited by 190
BRCA 1, a ‘complex’ protein involved in the maintenance of genomic stability
Savage, K. I., & Harkin, D. P. (2014) · FEBS Journal · doi:10.1111/febs.13150 · Cited by 183
Structure of the BRCT Repeats of BRCA1 Bound to a BACH1 Phosphopeptide
Shiozaki, E. N., Gu, L., Yan, N., & Shi, Y. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00238-2 · Cited by 174
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells
Konishi, H., Mohseni, M., Tamaki, A., Garay, J. P., Croessmann, S., Karnan, S., Ota, A., Wong, H. Y., Konishi, Y., Karakas, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110969108 · Cited by 170
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
Marini, H., Bitto, A., Altavilla, D., Burnett, B. P., Polito, F., Di Stefano, V., Minutoli, L., Atteritano, M., Levy, R. M., D'Anna, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1087 · Cited by 167
Contributions of ATM mutations to familial breast and ovarian cancer.
Thorstenson, Y. R., Roxas, A., Kroiss, R., Jenkins, M. A., Yu, K. M., Bachrich, T., Muhr, D., Wayne, T. L., Chu, G., Davis, R. W., et al. (2003) · PubMed · Cited by 162
Nanotechnology for breast cancer therapy
Tanaka, T., Decuzzi, P., Cristofanilli, M., Sakamoto, J. H., Tasciotti, E., Robertson, F. M., & Mauro Ferrari, B. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9209-0 · Cited by 159
Molecular mechanisms of the preventable causes of cancer in the United StatesPreprint
Golemis, E. A., Scheet, P. A., Beck, T. N., Scolnick, E. M., Hunter, D. J., Hawk, E. T., & Hopkins, N. H. (2018) · Genes & Development · doi:10.1101/gad.314849.118 · Cited by 164
Abbreviated Magnetic Resonance Imaging (MRI) for Breast Cancer Screening: Rationale, Concept, and Transfer to Clinical Practice
Kuhl, C. K. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-121417-100403 · Cited by 145
Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study
Bright, C. J., Reulen, R. C., Winter, D. L., Stark, D., McCabe, M. G., Edgar, A. B., Frobisher, C., & Hawkins, M. M. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30903-3 · Cited by 144
Collateral lethality: a new therapeutic strategy in oncology
Muller, F. L., Aquilanti, E. A., & DePinho, R. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.002 · Cited by 132
Nonrandom Distribution of Aberrant Promoter Methylation of Cancer-Related Genes in Sporadic Breast Tumors
Parrella, P., Poeta, M. L., Gallo, A. P., Prencipe, M., Scintu, M., Apicella, A., Rossiello, R., Liguoro, G., Seripa, D., Gravina, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0555 · Cited by 140
Emerging roles of BRCA1 alternative splicing
Orbán, T. I., & Oláh, E. (2003) · Molecular Pathology · doi:10.1136/mp.56.4.191 · Cited by 145
Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation
DelloRusso, C., Welcsh, P. L., Wang, W., Garcia, R. L., King, M., & Swisher, E. M. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0234 · Cited by 134
Self-citation
Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability
McCarthy, E. E., Celebi, J. T., Baer, R. J., & Ludwig, T. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.14.5056-5063.2003 · Cited by 140
Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation
Sluiter, M. D., & van Rensburg, E. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0817-z · Cited by 135
Genetic predisposition to cancer — insights from population genetics
Frank, S. A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1450 · Cited by 137
Understanding missense mutations in the BRCA1 gene: An evolutionary approach
Fleming, M., Potter, J. D., Ramirez, C. J., Ostrander, G. K., & Ostrander, E. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237285100 · Cited by 130
Chromosome 8q24-Associated Cancers and MYC
Grisanzio, C., & Freedman, M. L. (2010) · Genes & Cancer · doi:10.1177/1947601910381380 · Cited by 130
Identification of genes induced by BRCA1 in breast cancer cells
Atalay, A., Crook, T. J., Öztürk, M., & Yuluğ, I. G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02751-1 · Cited by 126
A curated gene list for reporting results of newborn genomic sequencing
Ceyhan‐Birsoy, O., Machini, K., Lebo, M. S., Yu, T. W., Agrawal, P. B., Parad, R. B., Holm, I. A., McGuire, A. L., Green, R. C., Beggs, A. H., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.193 · Cited by 122
Selective nanopore sequencing of human BRCA1 by Cas9-assisted targeting of chromosome segments (CATCH)
Gabrieli, T., Sharim, H., Fridman, D., Arbib, N., Michaeli, Y., & Ebenstein, Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky411 · Cited by 123
BRCA1 methylation: a significant role in tumour development?
Catteau, A., & Morris, J. R. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00056-1 · Cited by 121
Structural Determinants of BRCA1 Translational Regulation
Sobczak, K., & Krzyżosiak, W. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109162200 · Cited by 119
The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans
Moynahan, M. E. (2002) · Oncogene · doi:10.1038/sj.onc.1206177 · Cited by 114
Screening for a BRCA2 Rearrangement in High-Risk Breast/Ovarian Cancer Families: Evidence for a Founder Effect and Analysis of the Associated Phenotypes
Machado, P. M., Brandão, R. D., Cavaco, B. M., Eugénio, J. S., Bento, S., Nave, M., Rodrigues, P., Fernandes, A., & Vaz, F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9443 · Cited by 113
Anti-Inflammatory and Anticancer Effects of Anthocyanins in In Vitro and In Vivo Studies
Kowalczyk, T., Muskała, M., Merecz-Sadowska, A., Sikora, J., Picot, L., & Sitarek, P. (2024) · Antioxidants · doi:10.3390/antiox13091143 · Cited by 120
Increased error-prone non homologous DNA end-joining – a proposed mechanism of chromosomal instability in Bloom's syndrome
Gaymes, T. J., North, P. S., Brady, N., Hickson, I. D., Mufti, G. J., & Rassool, F. V. (2002) · Oncogene · doi:10.1038/sj.onc.1205331 · Cited by 114
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
Korde, L. A., Lusa, L., McShane, L. M., Lebowitz, P. F., Lukes, L., Camphausen, K. A., Parker, J. S., Swain, S. M., Hunter, K. W., & Zujewski, J. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0651-3 · Cited by 115
Pathway-based classification of cancer subtypes
Kim, S., Kon, M., & DeLisi, C. (2012) · Biology Direct · doi:10.1186/1745-6150-7-21 · Cited by 107
Risk of second cancers cancer after a first primary breast cancer: A systematic review and meta-analysis
Molina‐Montes, E., Requena, M., Sánchez‐Cantalejo, E., Fernández, M. F., Arroyo‐Morales, M., Espín, J., Arrebola, J. P., & Sánchez, M. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.10.029 · Cited by 107
BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations
Shah, S., Rachmat, R., Enyioma, S., Ghose, A., Revythis, A., & Boussios, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312628 · Cited by 113
BRCA1 Regulates RAD51 Function in Response to DNA Damage and Suppresses Spontaneous Sister Chromatid Replication Slippage: Implications for Sister Chromatid Cohesion, Genome Stability, and Carcinogenesis
Cousineau, I., Abaji, C., & Belmaaza, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2156 · Cited by 108
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper
Randall, L. M., Pothuri, B., Swisher, E. M., Diaz, J. P., Buchanan, A. H., Witkop, C., Powell, C. B., Smith, E. B., Robson, M. E., Boyd, J. A., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.06.002 · Cited by 107
DNA Damage and Pulmonary Hypertension
Ranchoux, B., Meloche, J., Paulin, R., Boucherat, O., Provencher, S., & Bonnet, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060990 · Cited by 111
Contribution of germline BRCA1 and BRCA2sequence alterations to breast cancer in Northern India
Saxena, S., Chakraborty, A., Kaushal, M., Kotwal, S. A., Bhatanager, D., Mohil, R. S., Chintamani, C., Aggarwal, A. K., Sharma, V. K., Sharma, P. C., et al. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-75 · Cited by 103
Telomere Shortening Occurs Early During Breast Tumorigenesis: A Cause of Chromosome Destabilization Underlying Malignant Transformation?
Meeker, A. K., & Argani, P. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048775.04140.92 · Cited by 100
How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?
Venkitaraman, A. R. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102668 · Cited by 111
Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families: Table 1
Woodward, A., Davis, T. A., Silva, A. G. S., Kirk, J. A., & Leary, J. A. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.027961 · Cited by 99
Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition
Pavlı́ček, A., Noskov, V. N., Kouprina, N., Barrett, J. C., Jurka, J., & Larionov, V. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh301 · Cited by 100
Mitochondrial DNA mutations and breast tumorigenesis
Yadav, N., & Chandra, D. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.10.002 · Cited by 96
Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
Gu, Z., Lee, R. Y., Skaar, T. C., Bouker, K. B., Welch, J. N., Lu, J., Liu, A., Zhu, Y. J., Davis, N., Leonessa, F., et al. (2002) · PubMed · Cited by 97
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
Li, M., & Yu, X. (2014) · Oncogene · doi:10.1038/onc.2014.295 · Cited by 99
New challenges for BRCA testing: a view from the diagnostic laboratory
Wallace, A. J. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.94 · Cited by 96
Germ‐line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen‐responsive proteins and the predominance of progesterone receptor A
Mote, P. A., Leary, J. A., Avery‐Kiejda, K. A., Sandelin, K., Chenevix‐Trench, G., Kirk, J., & Clarke, C. L. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10321 · Cited by 96
Serous tubal intraepithelial neoplasia: the concept and its application
Meserve, E. E. K., Brouwer, J., & Crum, C. P. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.238 · Cited by 94
Canine Mammary Cancer: State of the Art and Future Perspectives
Vazquez, E., Lipovka, Y., Cervantes-Arias, A., Garibay‐Escobar, A., Haby, M. M., QUEIROGA, F. L., & Velázquez, C. A. (2023) · Animals · doi:10.3390/ani13193147 · Cited by 98
Distinct functions of BRCA1 and BRCA2 in double-strand break repair
Liu, Y., & West, S. C. (2001) · Breast Cancer Research · doi:10.1186/bcr417 · Cited by 87
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland
Czarnecka, A. M., Krawczyk, T., Zdrożny, M., Lubiński, J., Arnold, R. S., Kukwa, W., Ścińska, A., Golik, P., Bartnik, E., & Petros, J. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0358-5 · Cited by 86
Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan
Lee, K., Chen, S., Chan, C. H., Lu, C.-H., Chen, C., Lin, J.-T., Chen, M., Huang, S., Yeh, C.-M., & Chen, M.-C. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0109 · Cited by 86
A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55
Nexø, B. A. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg043 · Cited by 85

Authors: Welcsh, P. L.
Affiliations: University of Washington (US)
Corresponding author: Welcsh, P. L.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2001-04-01
Volume: 10
Issue: 7
Pages: 705-713
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/10.7.705
OpenAlex: W2124371549
Cited by: 648
References: 93
Citations by year: 2026: 11 · 2025: 16 · 2024: 25 · 2023: 19 · 2022: 19 · 2021: 26 · 2020: 27 · 2019: 33 · 2018: 30 · 2017: 36 · 2016: 34 · 2015: 31 · 2014: 29 · 2013: 25 · 2012: 17
FWCI: 4.10
Type: journal article
Language: en
Open access: closed
Locations: Human Molecular Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ca027632-22)
National Cancer Institute (CA27632)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords: BRCA1, BRCA2, hereditary breast cancer, hereditary ovarian cancer, germline mutations, somatic mutations, DNA repair, transcriptional regulation, repetitive elements, chromosomal instability, genome rearrangement, carcinogenesis, tumor suppressor
MeSH terms: Breast Neoplasms, Cell Division, Chromosomes, Estrogens, Female, Humans, Models, Biological, Mutation, Neoplasm Proteins, Ovarian Neoplasms, Repetitive Sequences, Nucleic Acid, Transcription Factors, Gene Deletion, Genes, BRCA1, Genetic Predisposition to Disease, BRCA2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks